Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
August-2017 Volume 16 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
August-2017 Volume 16 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Human amnion-derived mesenchymal stem cells protect against UVA irradiation-induced human dermal fibroblast senescence, in vitro

  • Authors:
    • Chunli Zhang
    • Haishen Yuchi
    • Lu Sun
    • Xiaoli Zhou
    • Jinde Lin
  • View Affiliations / Copyright

    Affiliations: Department of Clinical Research, Friendship Plastic Surgery Hospital, Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China
    Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 2016-2022
    |
    Published online on: June 15, 2017
       https://doi.org/10.3892/mmr.2017.6795
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The aim of the present study was to determine if human amnion‑derived mesenchymal stem cells (HAMSCs) exert a protective effect on ultraviolet A (UVA) irradiation-induced human dermal fibroblast (HDF) senescence. A senescence model was constructed as follows: HDFs (104‑106 cells/well) were cultured in a six‑well plate in vitro and then exposed to UVA irradiation at 9 J/cm2 for 30 min. Following the irradiation period, HDFs were co‑cultured with HAMSCs, which were seeded on transwells. A total of 72 h following the co‑culturing, senescence‑associated β‑galactosidase staining was performed and reactive oxygen species (ROS) content and mitochondrial membrane potential (Δψm) were detected in the HDFs via flow cytometric analysis. The results demonstrated that the percentage of HDFs, detected via staining with X‑gal, were markedly decreased when co‑cultured with human HAMSCs, compared with the group that were not co‑cultured. The ROS content was decreased and the mitochondrial membrane potential (Δψm) recovered in cells treated with UVA and HAMSCs, compared with that of cells treated with UVA alone. Reverse transcription‑quantitative polymerase chain reaction revealed the significant effects of HAMSCs on the HDF senescence marker genes p53 and matrix metalloproteinase‑1 mRNA expression. In addition to this, western blot analysis verified the effects of HAMSCs on UVA induced senescence, providing a foundation for novel regenerative therapeutic methods. Furthermore, the results suggested that activation of the extracellular‑signal regulated kinase 1/2 mitogen activated protein kinase signal transduction pathway, is essential for the HAMSC‑mediated UVA protective effects. The decrease in ROS content additionally indicated that HAMSCs may exhibit the potential to treat oxidative stress‑mediated UVA skin senescence in the future.

Introduction

Skin is an essential natural barrier protecting body from physical, chemical and microbial hazards, also a visual indicator of body's aging process (1). 90%of the ultraviolet (UV) reaching surface of the earth is long-wavelength irradiation (UVA, 320–400 nm), which can penetrate the epidermis into the dermis. So it is well established that UVA is responsible for skin photoaging induced by UV. Studies demonstrated UVA radiation can induce cytokine expression in human epidermoid carcinoma cells. UVA radiation caused an increased proportion of β-Gal positive cells and reduced telomere length in human skin fibroblasts. In addition, UVA radiation inhibited TGF-β 1 secretion, induced G1 phase arrest, reduced SOD and GSH-Px levels, increased MDA levels and the expression of MMP-1, TIMP-1, p66, p53 mRNA expression (2,3).

Human amnion-derived mesenchymal stem cells (HAMSCs) obtained from human amniotic membrane (AM) are readily available and high abundant tissue, with substantial benefits as seed cells (3,4). Their low anti-flammatory properties and fewer ethical concerns compared with other sources of stem cell are clear advantage (5–7). It is proved that HAMSCs secrete a variety of cytokines, which is essential to a series of basic biological processes of cells (8). Recent studies revealed that HAMSCs have important roles in cell differentiation (9–12), promoting cell proliferation (13–15), enhancing cell viability and function (16–18), protecting cells from adverse effects and inhibiting apoptosis (19,20) in vivo or in vitro. The present study aimed to determine whether HAMSCs involved in the protection of human dermal fibroblasts (HDFs) from UVA-induced senescence.

In order to investigate the protective mechanisms of HAMSCs against UVA-induced HDFs senescence, an in vitro cell-senescence model was built through the exposure of pre-HAMSCs-treated HDFs to UVA, and the effects of HAMSCs on ROS contents and mitochondrial membrane potential (Δψm), HDFs senescence marker genes p53 and MMP1 (21) expression were detected by reverse transcription quantitative polymerase chain reaction analysis and western blot. Furthermore, senescence-associated β-galactosidase (SA-β-Gal) staining was performed to evaluate the senescence status of HDFs. SA-β-Gal activity distinguishes senescent cells from those terminally differentiated, therefore act as a senescence biomarker. Our results showed that HAMSCs up-regulated MERK1/2 in UVA induced senescence HDFs, which means skin senescence might related to ERK1/2 MAPK signal pathway.

Materials and methods

Chemicals and reagents

Fetal bovine serum (FBS), α-minimum essential medium (αMEM), trypsin-EDTA, phosphate-buffered saline (PBS) and penicillin G-streptomycin sulfate were purchased from Gibco Life Technologies (Carlsbad, CA, USA). 2,7-dichlorodihydro fluoresceindiacetate (DCFH-DA) fom Sigma-Aldrich (St. Louis, MO, USA). Transwells (6-well millicell Hanging Cell Culture Inserts, 0.4 µm, PET) and 6-well culture plates were purchased from Millipore Corp. (Billerica, MA, USA). The goat anti rabbit IgG, phosphor-p44/42 MAPK rabbit mAb (p-ERK1/2), JNK MAPK rabbit mAb, p53 rabbit mAb, SIRT1 rabbit mAb and Senescence β-Galactosidase Staining kit were purchased from Cell Signaling Technology, Inc. (3 Trask Lane; Danvers, MA, USA). Penicillin and streptomycin from Gibco Life Technologies. Other reagents used were of the highest commercial grade available.

Cell culture

Human amnion-derived mesenchymal stem cells were prepared as described previously (3). Briefly, human amniotic membrane was mechanically peeled off from the chorion of a placenta obtained from an uncomplicated elective caesarean section with the informed consent of the donor patient. The HAMSCs layer was thoroughly scraped out from the underlying tissues such as the spongy and fibroblast layers. Within 24 h AM layer was then treated with 0.125% trypsin three times each for 20 min to obtain dissociated HAMSCs. The cells were cultured in α-MEM supplemented with 10% FBS, penicillin (100 U/ml) and streptomycin (100 µg/ml), incubated in an incubator at 37°C with 5% CO2 in a humidified atmosphere. The culture medium was changed every 3 days.

Primary HDFs were purchased from Wuxi BioHermes Bio&Medical Technology Co., Ltd. (Wuxi, China). Cultured in a 10-cm dish in α-MEM supplemented with 10% fetal bovine serum, penicillin (100 U/ml) and streptomycin (100 µg/ml).

The Co-culture system

The transwell co-culture system was used to investigate the effects of HAMSCs on HDFs. HDFs were seeded at an initial density of 5×104 cells/cm2 in 6-well culture plates. Transwells were placed in other 6-well culture plates and seed at increasing HAMSCs (5×104 cells/transwell, 10×104 cells/transwell and 15×104 cells/transwell). Immediately after 9 J/cm2 UVA on HDFs to create UVA induced senescence, HAMSCs in transwells moved into the appropriate well of 6-well plate to co-culturing with HDFs. HDFs in wells with HAMSCs on transwells served as the treatment groups, while HDFs without transwells were designated as the control group.

UVA irradiation

24 h after HDFs seeded in the six-well plate, HDFs were exposed to 9 J/cm2 (30 min) UVA irradiation. Cells were washed with phosphate-buffered saline (PBS) and covered with a thin layer of PBS prior to UVA exposure. The culture plate lid was removed, and the 6-well plate was placed on a brass block embedded on ice, in order to reduce any evaporation, at a distance of 15 cm from the UVA light source. As the UVA irradiation source, an Ultraviolet phototherapy instrument (SS-04A; Shanghai Sigma High-tech Co., Ltd., Shanghai, China) equipped with a 15-W ozone-free UVA lamp (CEL015 W; Philips, Groningen, The Netherlands) was used. The incidence dose of UVA was measured with a UVA/UVB-ultraviolet meter (Factory affiliated to Beijing Normal University, Beijing, China). After UVA irradiation, PBS was replaced with culture medium and transwells seeded with HAMSCs were placed in wells of the co-culture group, then they were incubated under standard conditions for 72 h prior to analysis.

Analysis of cellular proliferation

HDFs accepted UVA irradiation then co-cultured with HAMSCs after 72 h, transwells containg HAMSCs were removed and HDFs were harvested. After fixed with 75% ice-cold ethanol at 4°C in the dark, cell cycle fractions (G0, G1, and G2, M phase) were determined by flow cytometry.

SA-β-Gal staining

SA-β-Gal activity was evaluated using a β-galactosidase staining kit (Beyotime Institute of Biotechnology, Haimen, China). Cells were washed with PBS and fixed for 15 min at room temperature with fixative solution. The HDFs cells were then incubated at 37°C overnight. SA-β-Gal-positive staining was expressed as a percentage of the total number of cells; cell numbers were counted in four continuous visual fields using a microscope (Olympus CX51; Olympus, Tokyo, Japan; total magnification, ×20).

Assessment of ROS production

The level of ROS induced by UVA in HDFS was measured using DCFH-DA as a fluorescent probe. After irradiation and co-culturing with HAMSCs, transwells were removed and HDFs were washed three times with PBS, incubated with DCFH-DA (10 mM) for 30 min at 37°C, washed three times with PBS. Macrographs of DCFDA fluorescence were immediately.

Flow cytometry analysis of mitochondrial membrane potential

Mitochondrial membrane potential (Δψm) was analyzed by a fluorescent dye JC-1 (Beyotime Institute of Biotechnology), following manufactur's protocol. JC-1 is capable of selectively entering mitochondria where it forms monomers and emits green fluorescence (530 nm) when Δψm is relatively low. At high Δψm, JC-1 aggregates and gives a red fluorescence (590 nm). Assays were initiated by incubating HDFs with JC-1 for 30 min at 37°C in the dark and the fluorescence of separated cells was detected with a flow cytometer (FAC-SCalibur; BD Biosciences, San Diego, CA, USA). Δψm was determined by a ratio of fluorescence intensity at 590 nm to that at 530 nm. A minimum of 10,000 cells per sample was acquired and analyzed.

Assessment of senescence related RNA and protein

Total RNA was extracted from the cells using TRIzol reagent (Promega Corp., Madison, WI, USA). RNA concentration and purity were determined with a Nanodrop 2000-UV spectrophotometer (Thermo Fisher Scientific, Inc., Waltham, MA, USA). Ribosomal RNA band integrity was evaluated using conventional denaturing agarose gel electrophoresis using the SDS-PAGE gel quick preparation kit (Beyotime Institute of Biotechnology). Equal amounts of RNA (500 ng) from each sample were reverse transcribed using a PrimeScript™ RT Reagent kit with gDNA Eraser (Takara Bio, Dalian, China) according to the manufacturer's instructions. qPCR was performed using SYBR-Green dye method (Premix Ex Taq; Takara Bio) using an ABI700 Real-Time PCR detection system (Applied Biosystems; Life Technologies, Thermo Fisher Scientific, Inc.). The following standard cycling conditions for qPCR were applied: 95°C for 3 min to activate polymerase, 40 cycles of denaturation at 95°C for 15 sec and annealing-extension at 60°C for 30 sec. Melting curve analysis was performed following every run by defined heating up to 95°C to assess the presence of unspecific PCR products. Specific primers for the RT-qPCR reactions were as follows: MMP1 forward, 5′-TTGGAGGGGATGCTCATT-3′ and, reverse, 5′-TAAAACGCAGCTCAGTAACAGTCCG-3′; p53, forward, 5′-AGAATCTCCGCAAGAAAGG-3′, reverse, 5′-GCTGGTATGTCCTACTCCC-3′; β-actin, forward, 5′-TGGAATCTTGCTCTTATTTTCACA-3′ and reverse, 5′-TAAAACGCAGCTCAGTAACAGTCCG-3′. All primers were synthesized by Sangon Biotech, Co., Ltd. (Shanghai, China) and used at 400 nM expect for β-actin at 300 nM. All PCR efficiencies were between 90 and 110%.

At the end of 72 h after UVA irradiation and co-culture, transwells containg HAMSCs were removed and HDFs in each group were lysed in RIPA buffer containg 1 mM phenylmethane sulfonylfuoride according to the manufacturer's instructions. The total protein concentration was determined using a bicinchoninic acid (BCA) assay kit. Protein lysates (20 µg) were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and then transferred onto 0.22 µm polyvinylidene difluofide membranes (Millipore Corp.). After blocking, membranes were incubated overnight at 4°C with specific antibodies for the detection of p53 (1:1,000), p38 (1:1,000), SIRT1 (1:1,000), p-ERK1/2 (1:500), ERK1/2 (1:500). After three washes with PBST (0.5% Tween-20 in PBS), the membranes were incubated with the relevant secondary antibodies (1:2,000) for 1 h at 37°C, washed and visualized with an ECL detection kit (Amersham Pharmacia Biotech, Piscataway, NJ, USA). The GAPDH (1:500) served as internal control.

Statistical analysis

Analyses were performed using GraphPad Prism software (GraphPad Inc., La Jolla, CA, USA). Values are presented as the mean ± standard deviation. The one-way analysis of variance was used for comparisons involving more than two groups. P<0.05 was considered to indicate a statistically significant difference.

Results

HAMSCs promoted UVA induced HDFs proliferation and reduce UVA induced HDFs senescence

Flow cytometry were used to measure the proliferation of UVA treated HDFs seeded in the 6-well plates co-culture with HAMSCs. Cell cycle fractions (G0, G1, S, and G2, M phase) were determined by flow cytometry at 72 h after UVA and HAMSCs treatment. The S phase showed significant inhibited treated by UVA, after co-culture with HAMSCs the S-phase checkpoints increased (Fig. 1A). So we chose 10×104 cells/transwell HAMSCs in following experiment. Our results further demonstrated that co-culturing with HAMSCs accelerated UVA-induced HDFs proliferation.

Figure 1.

The effect of HAMSCs on UVA induced HDFs proliferation and senescence by flow cytometry and X-gel staining. Transwells containing HAMSCs were moved into the correlating wells containing HDFs which accepted 9 J/cm2 UVA irradiation. (A) HDFs cell cycle fractions (G0, G1, S, and G2, M phase) were detected at 72 h after UVA irradiation and co-culture or without HAMSCs. (B) SA-β-gal staining was taken 72 h after irradiation and co-culturing with/without HAMSCs, the stained surface was measured by image-pro plus 6.0 (IPP) analysis. Values are means ± SD of 3 independent experiments with each performed in triplicate. #P<0.05 vs. the HDFs group; ##P<0.01 vs the HDFs group; *P<0.05 and **P<0.01 compared with the group treated with UVA alone.

X-gal staining results showed that the percentage of cells stained by X-gal following 9 J/cm2 UVA irradiation was markedly increased compared with that of the control group (10.8 and 22.6%, respectively; P<0.05), while HAMSCs attenuated the ratio of positive staining compared with that of the UVA-treated only cells (15.3 and 22.6%, respectively; P<0.05) (Fig. 2B).

Figure 2.

Flow cytometry of ROS generation and mitochondria depolarization in UVA irradiated HDFs after co-culturing with or without HAMSCs for 72 h or without. Transwells containing HAMSCs were moved into the correlating wells containing HDFs which just accepted 9 J/cm2 UVA irradiation. (A) Macrogaphs of DCFDA fluorescence was determined by flow cytometry at 72 h after UVA irradiation and co-culturing with/without HAMSCs. (B) JC-1 fluorescence was determined by flow cytometry at 72 h after UVA irradiation and co-culture with or without HAMSCs. ##P<0.01 vs the HDFs group; *P<0.05 and **P<0.01 compared with the group treated with UVA alone. Values are means ± SD of 3 independent experiments with each performed in triplicate.

HAMSCs inhibited ROS generation and mitochondria depolarization in UVA induced HDFs

To elucidate whether the beneficial effects of HAMSCs were linked to their antioxidant properties, the ROS generation in UVA-induced HDFs were measured. Subsequently, the intensity of fluorescence was determined by flow cytometry.

As shown in Fig. 2A, after UVA irradiation, intracellular ROS generation increased significantly. The level of ROS in UVA treated cells was much higher than the level of ROS in control cells throughout the experiment. Co-culture with HAMSCs significantly inhibited the elevated intracellular concentration of ROS.

Loss of mitochondrial membrane potential in cells has been estimated using JC-1 assay kit. In normal cells, JC-1 aggregated in mitochondria and the ratio was 124.29. UVA irradiation treated cells showed the higher ratio 785.22, which indicated the dissipation of Δψm. HDFs treatedwith UVA and co-cultured with HAMSCs demonstrated attenuation of the dissipation of Δψm 288.56 (Fig. 2B). Above results uggested that HAMSCs protect mitochondria depolarization induced by UVA irradiation.

HAMSCs reduced the expression of senescence related markers

Reverse transcription quantitative polymerase chain reaction analysis showed mRNA expression levels of p53 and MMP1 were significantly reduced in UVA-treated HDFs co-cultured with HAMSCs than that of the UVA-treated only group (P<0.05) (Fig. 3A). In order to further study the efficacy of HAMSCs, western blot analysis was to evaluate the protein expression in co-culture with UVA and HAMSCs or with UVA only of HDFs. The result showed that HAMSCs had a significant effect on p53, active-MMP1 and SIRT1 (Fig. 2B).

Figure 3.

Expression of senescence related markers. Transwells containing HAMSCs were moved into the correlating wells containing HDFs which accepted 9 J/cm2 UVA irradiation. (A) mRNA expression of MMP1 and p53 in UVA irradiated HDFs co-culturing with or without HAMSCs for 72 h. (B) Expression of p53, MMP1 and SIRT1 in UVA irradiated HDFs co-culturing with or without HAMSCs were determined by western blot, GAPDH served as an internal control. Values are means ± SD of 3 independent experiments with each performed in triplicate. ##P<0.01 vs the HDFs group; **P<0.01 compared with the group treated with UVA alone.

HAMSCs activated ERK1/2 in UVA induced HDFs

EEK1/2 are important members of the MAPK signal pathway, which regulates the differentiation, mineralization and proliferation of HDFs. Fig. 4 showed ERK1/2 in HDFs in respective of UVA treatment after 72 h with or without co-culture with HAMSCs. Higher level of phosohorylated ERK1/2 were observed compared with UVA irradiated HDFs co-cultured with HAMSCs than without. These results suggested that HAMSCs enhance UVA-induced inhibition of ERK1/2, which might play a role in regulating UVA induced HDF senescence.

Figure 4.

Expression of ERK1/2, p-ERK1/2 in UVA irradiated HDFs after co-culturing with or without HAMSCs for 72 h. Transwells containing HAMSCs were moved into the correlating wells containing HDFs which accepted 9 J/cm2 UVA irradiation. Densitometric measures of the band intensity are expressed as the signal ratios indicating the level of ERK phosphorylation (p-ERK1/2 ERK1/2). ##P<0.01 vs the HDFs group; **P<0.01 compared with the group treated with UVA alone. Values are means ± SD of 3 independent experiments with each performed in triplicate.

Discussion

HAMSCs has been the shining star in cell-based therapy in recent years, which appear to have several advantages over other stem cell lineages as a cell therapy. Studies showed that HAMSCs can maintain mouse spermatogonial stem cells in an undifferentiated state when cultured long term due to high leukemia inhibitor factor (LIF) expression. HAMSCs had an increased proliferative capacity, higher colony-forming efficiency, fewer apoptotic cells, and similar cell-junction formation capabilities and pump functionality compared with primary HCECs (21,22). Amniotic membrane can restrict dedifferentiation of human retinal pigment epithelial cells (RPE cells) in culture, promoting RPE65, CRALBP, VEGF, CD68, and tyrosinase gene expression in RPE cells (23). Experiments have demonstrated the ability of HAMSCs to migrate into brain, prevents the degeneration of nigral dopmineneurons in rats with 6-hydroxydopami-ne lesions (24). HAMSCs transplantation promotes ovarian function by inhibiting tumor necrosis factor-alpha-mediated cell apoptosis and reducing inflammation in chemotherapy-induced premature ovarian failure (25). HAMSCs are able to produce/release a number of biologically active cytokines/growth modulators, such as basic fibroblast growth factor (bFGF), epithelial growth factor (EGF), insulin growth factor-1 (IGF-1), stem cell factor (SCF), IL-1a, IL-10, insulin, tumor necrosis factor-a, IFN-g, and leukemia inhibitory factor (LIF), some of which could constitute crucial components in maintaining/enhancing the survival/anti-senescence/apoptosis of progenitor/adult cells (26). HAMSCs can secrete several cytokines and growth factors, promoting the survival of the surrounding cells. The cytokines and the growth factors, such as IL-6, M-CSF, IL-10, HGF, TGF-β and PGE2 contribute to preventing apoptosis of injured pancreatic β-cells and enhancing regeneration of endogenous progenitor cells via angiogenic, cytoprotective, anti-inflammatory, mitogenic and anti-apoptotic effects (21).

It was reported that mitochondria use oxidative phosphorylation to convert dietary intake into ATP; in the process, they generate ROS, which can damage mitochondrial DNA, impair respiratory chain function, and cause nuclear DNA damage and cellular checkpoint activation (27). p53 is a transcription factor that plays a key role in both cell cycle arrest and apoptosis. p53 has many anticancer mechanisms and plays a role in apoptosis, genetic stability, and inhibition of senescence/apoptosis (28).

Present study was to investigate the potential molecular signaling pathways of UVA-induced HDF senescence engaged by HAMSCs. We found that HAMSCs promoted proliferation in UVA induced HDFs which confirmed by flow cytometry. SA-β-gel staining revealed that senescence of UVA irradiated HDFs co-cultured with HAMSCs decreased compared with HDFs accepted UVA irradiation only. ROS generation in UVA induced HDFs was determined to measure the anti-oxidant properties. The excessive production of ROS, such as superoxides and H2O2 severely damages the DNA, protein and lipids. Our findings suggest that HAMSCs inhibited ROS generation in UVA-induced HDFs. Expression of MMP, p53, p38, SIRT1 were also significantly increased in the co-culture group. By improving senescence against oxidative stress, HAMSCs might represent an appropriate therapeutic alternative against UVA induced skin aging.

Signal pathways involved in oxidative stress-induced inhibition of senescence consist of MAPK, Akt/mTOR/4EBP1, p53 and NFκB [Sreedhar et al (29), 2016]. The present study highlights the antioxidant role of HAMSCs in promoting UVA-induced proliferation and senescence. We found that activation of the ERK/MAPK signaling pathway is essential for protective effect against oxidative stress induced cell injury in HDFs. These data shed light on the molecular mechanism the signaling cascade mediated by HAMSCs and identify the potential role of HAMSCs in tissue engineering.

Acknowledgements

The present study was support by the Nanjing Medical Science and Technology Development Fund Project (grant no. 2015NJMUZD088).

References

1 

He YY, Council SE, Feng L and Chignell CF: UVA-induced cell cycle progression is mediated by a disintegrin and metalloprotease/epidermal growth factor receptor/AKT/Cyclin D1 pathways in keratinocytes. Cancer Res. 68:3752–3758. 2008. View Article : Google Scholar : PubMed/NCBI

2 

Morita A, Grewe M, Grether-Beck S, Olaizola-Horn S and Krutmann J: Induction of proinflammatory cytokines in human epidermoid carcinoma cells by in vitro ultraviolet A1 irradiation. Photochem Photobiol. 65:630–635. 1997. View Article : Google Scholar : PubMed/NCBI

3 

Min W, Liu X, Qian Q, Lin B, Wu D, Wang M, Ahmad I, Yusuf N and Luo D: The Effects of baicalin against UVA-induced photoaging in skin fibroblasts. Am J Chin Med. 42:709–727. 2014. View Article : Google Scholar : PubMed/NCBI

4 

Ilancheran S, Michalska A, Peh G, Wallace EM, Pera M and Manuelpillai U: Stem cells derived from human fetal membranes display multilineage differentiation potential. Biol Reprod. 77:577–588. 2007. View Article : Google Scholar : PubMed/NCBI

5 

Miki T, Lehmann T, Cai H, Stolz DB and Strom SC: Stem cell characteristics of amniotic epithelial cells. Stem Cells. 23:1549–1559. 2005. View Article : Google Scholar : PubMed/NCBI

6 

Song YS, Joo HW, Park IH, Shen GY, Lee Y, Shin JH, Kim H, Shin IS and Kim KS: Transplanted human amniotic epithelial cells secrete paracrine proangiogenic cytokines in rat model of myocardial infarction. Cell Transplant. 24:2055–2064. 2015. View Article : Google Scholar : PubMed/NCBI

7 

Chen YT, Li W, Hayashida Y, He H, Chen SY, Tseng DY, Kheirkhah A and Tseng SC: Human amniotic epithelial cells as novel feeder layers for promoting ex vivo expansion of limbal epithelial progenitor cells. Stem Cells. 25:1995–2005. 2007. View Article : Google Scholar : PubMed/NCBI

8 

Lai D, Wang Y, Sun J, Chen Y, Li T, Wu Y, Guo L and Wei C: Derivation and characterization of human embryonic stem cells on human amnion epithelial cells. Sci Rep. 5:100142015. View Article : Google Scholar : PubMed/NCBI

9 

Banas R, Miller C, Guzik L and Zeevi A: Amnion-derived multipotent progenitor cells inhibit blood monocyte differentiation into mature dendritic cells. Cell Transplant. 23:1111–1125. 2014. View Article : Google Scholar : PubMed/NCBI

10 

Díaz-Prado S, Muiños-López E, Hermida-Gómez T, Cicione C, Rendal-Vázquez ME, Fuentes-Boquete I, de Toro FJ and Blanco FJ: Human amniotic membrane as an alternative source of stem cells for regenerative medicine. Differentiation. 81:162–171. 2011. View Article : Google Scholar : PubMed/NCBI

11 

Díaz-Prado S, Muiños-López E, Hermida-Gómez T, Rendal-Vázquez ME, Fuentes-Boquete I, de Toro FJ and Blanco FJ: Multilineage differentiation potential of cells isolated from the human amniotic membrane. J Cell Biochem. 111:846–857. 2010. View Article : Google Scholar : PubMed/NCBI

12 

Han K, Lee JE, Kwon SJ, Park SY, Shim SH, Kim H, Moon JH, Suh CS and Lim HJ: Human amnion-derived mesenchymal stem cells are a potential source for uterine stem cell therapy. Cell Prolif. 41:705–725. 2008. View Article : Google Scholar

13 

Onishi R, Onishi S, Higashi R, Yamahara K, Yoshimatsu J, Katsurada T, Okubo N, Nakagawa K, Takeda H and Sakamoto N: The anti-inflammatory effect of human annion-derived mesenchymal stem cells. Placenta. 35:A232014. View Article : Google Scholar

14 

Lee JH, Ryu IH, Kim EK, Lee JE, Hong S and Lee HK: Induced expression of insulin-like growth factor-1 by amniotic membrane-conditioned medium in cultured human corneal epithelial cells. Invest Ophthalmol Vis Sci. 47:864–872. 2006. View Article : Google Scholar : PubMed/NCBI

15 

Ohno-Matsui K, Ichinose S, Nakahama K, Yoshida T, Kojima A, Mochizuki M and Morita I: The effects of amniotic membrane on retinal pigment epithelial cell differentiation. Mol Vis. 11:1–10. 2005.PubMed/NCBI

16 

Akrami H, Soheili ZS, Sadeghizadeh M, Khalooghi K, Ahmadieh H, Kanavi MR, Samiei S and Pakravesh J: Evaluation of RPE65, CRALBP, VEGF, CD68, and tyrosinase gene expression in human retinal pigment epithelial cells cultured on amniotic membrane. Biochem Genet. 49:313–322. 2011. View Article : Google Scholar : PubMed/NCBI

17 

Yan ZJ, Zhang P, Hu YQ, Zhang HT, Hong SQ, Zhou HL, Zhang MY and Xu RX: Neural stem like cells derived from human amnion tissue are effective in treating traumatic brain injury in rat. Nerochem Res. 38:1022–1033. 2013. View Article : Google Scholar

18 

Nogami M, Tsuno H, Koike C, Okabe M, Yoshida T, Seki S, Matsui Y, Kimura T and Nikaido T: Isolation and characterization of human amniotic mesenchymal stem cells and their chondrogenic differentiation. Transplantation. 93:1221–1228. 2012. View Article : Google Scholar : PubMed/NCBI

19 

Lim H, Han K, Lee J, Shim S, Moon J, Suh C, Kim J and Kim H: Human amnion derived mesenchymal stem cells may have potential to contribute and differentiate endometrial cells in vivo. Hum Reprod. 22:i1712007.

20 

Tamagawa T, Ishiwata I, Ishikawa H and Nakamura Y: IInduced in-vitro differentiation of neural-like cells from human amnion-derived fibroblast-like cells. Hum Cell. 21:38–45. 2008. View Article : Google Scholar : PubMed/NCBI

21 

Niknejad H, Yazdanpanah G and Ahmadiani A: Induction of apoptosis, stimulation of cell-cycle arrest and inhibition of angionenesis make human amnion-derived cells promising sources for cell therapy of cancer. Cell Tissue Res. 363:599–608. 2016. View Article : Google Scholar : PubMed/NCBI

22 

Lei LT, Chen JB, Zhao YL, Yang SP and He L: Resveratrol attenuates senescence of adipose-derived mesenchymal stem cells and restores their paracrine effects on promoting insulin secretion of INS-1 cells through Pim-1. Eur Rev Med Pharmacol Sci. 20:1203–1213. 2016.PubMed/NCBI

23 

Kawakubo K, Ohnishi S, Fujita H, Kuwatani M, Onishi R, Masamune A, Takeda H and Sakamoto N: Effect of fetal membrane-derived mesenchymal stem cell transplantation rats with acute and chronic pancreatitis. Pancreas. 45:707–713. 2016. View Article : Google Scholar : PubMed/NCBI

24 

Ono M, Ohnishi S, Honda M, Ishikawa M, Hosono H, Onishi R, Nakagawa K, Takeda H and Sakamoto N: Effects of human amnion-derived mesenchymal stromal cell transplantation in rats with radiation proctitis. Cytotherapy. 17:1545–1559. 2015. View Article : Google Scholar : PubMed/NCBI

25 

Li J, Koike-Soko C, Sugimoto J, Yoshida T, Okabe M and Nikaido T: Human amnion-derived stem cells have immunosuppressive properties on NK cells and monocytes. Cell Transplant. 24:2065–2076. 2015. View Article : Google Scholar : PubMed/NCBI

26 

Sahin E, Colla S, Liesa M, Moslehi J, Müller FL, Guo M, Cooper M, Kotton D, Fabian AJ, Walkey C, et al: Telomere dysfunction induces metabolic and mitochondrial compromise. Nature. 470:359–365. 2011. View Article : Google Scholar : PubMed/NCBI

27 

Hengartner MO: The biochemistry of apoptosis. Nature. 407:770–776. 2000. View Article : Google Scholar : PubMed/NCBI

28 

Vogelstein B, Lane D and Levine AJ: Surfing the p53 network. Nature. 408:307–310. 2000. View Article : Google Scholar : PubMed/NCBI

29 

Sreedhar R, Giridharan W, Arumugam S, Karuppagounder V, Palaniyandi SS, Krishnamurthy P, Quevedo J, Watanabe K, Konishi T and Thandavarayan RA: Role of MAPK-mediated endoplasmic reticulum stress signaling in the heart during aging in senescence-accelerated prone mice. Biofactors. 42:368–375. 2016. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhang C, Yuchi H, Sun L, Zhou X and Lin J: Human amnion-derived mesenchymal stem cells protect against UVA irradiation-induced human dermal fibroblast senescence, in vitro. Mol Med Rep 16: 2016-2022, 2017.
APA
Zhang, C., Yuchi, H., Sun, L., Zhou, X., & Lin, J. (2017). Human amnion-derived mesenchymal stem cells protect against UVA irradiation-induced human dermal fibroblast senescence, in vitro. Molecular Medicine Reports, 16, 2016-2022. https://doi.org/10.3892/mmr.2017.6795
MLA
Zhang, C., Yuchi, H., Sun, L., Zhou, X., Lin, J."Human amnion-derived mesenchymal stem cells protect against UVA irradiation-induced human dermal fibroblast senescence, in vitro". Molecular Medicine Reports 16.2 (2017): 2016-2022.
Chicago
Zhang, C., Yuchi, H., Sun, L., Zhou, X., Lin, J."Human amnion-derived mesenchymal stem cells protect against UVA irradiation-induced human dermal fibroblast senescence, in vitro". Molecular Medicine Reports 16, no. 2 (2017): 2016-2022. https://doi.org/10.3892/mmr.2017.6795
Copy and paste a formatted citation
x
Spandidos Publications style
Zhang C, Yuchi H, Sun L, Zhou X and Lin J: Human amnion-derived mesenchymal stem cells protect against UVA irradiation-induced human dermal fibroblast senescence, in vitro. Mol Med Rep 16: 2016-2022, 2017.
APA
Zhang, C., Yuchi, H., Sun, L., Zhou, X., & Lin, J. (2017). Human amnion-derived mesenchymal stem cells protect against UVA irradiation-induced human dermal fibroblast senescence, in vitro. Molecular Medicine Reports, 16, 2016-2022. https://doi.org/10.3892/mmr.2017.6795
MLA
Zhang, C., Yuchi, H., Sun, L., Zhou, X., Lin, J."Human amnion-derived mesenchymal stem cells protect against UVA irradiation-induced human dermal fibroblast senescence, in vitro". Molecular Medicine Reports 16.2 (2017): 2016-2022.
Chicago
Zhang, C., Yuchi, H., Sun, L., Zhou, X., Lin, J."Human amnion-derived mesenchymal stem cells protect against UVA irradiation-induced human dermal fibroblast senescence, in vitro". Molecular Medicine Reports 16, no. 2 (2017): 2016-2022. https://doi.org/10.3892/mmr.2017.6795
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team